|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5050 EUR | +5.83% |
|
+4.77% | -85.08% |
| 06-30 | Biosergen AB Appoints Mattias Klintemar as Chairman of the Board | CI |
| 06-29 | Life Science Investor Flerie to Acquire Biosergen | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.21% | +25.56% | +30.85% | +51.07% | +78.00% | +77.96% | +104.49% | +10.76% | - | 70.85B | |
| -0.86% | +6.20% | +0.42% | +14.34% | +7.00% | +34.94% | +67.83% | +189.00% | +5,543.86% | 55.41B | |
| +2.78% | +36.87% | +16.56% | +32.96% | -22.58% | +23.00% | +493.09% | +457.05% | +1,078.92% | 29.43B | |
| -0.30% | +18.87% | +21.50% | +41.21% | +46.69% | +57.08% | +5.18% | -63.83% | - | 24.12B | |
| -0.93% | +0.60% | +1.43% | -1.41% | -2.52% | -16.89% | -12.00% | -77.72% | - | 23.31B | |
| +0.55% | +7.91% | +6.61% | +21.35% | -1.73% | +44.14% | -22.61% | -30.59% | +70.69% | 18.37B | |
| +7.26% | +14.16% | +3.50% | +103.78% | +213.90% | +221.03% | +393.89% | +1,651.05% | +780.23% | 16.99B | |
| 0.00% | +10.84% | +2.32% | +18.18% | +34.75% | +31.14% | +628.97% | - | - | 16.1B | |
| -2.05% | -3.81% | -6.27% | +9.97% | +20.83% | +40.40% | +150.40% | +207.73% | +410.70% | 13.12B | |
| +0.78% | +2.70% | +15.62% | +21.52% | +33.05% | +437.94% | +204.90% | +44.31% | +1,415.09% | 12.48B | |
| +0.39% | +10.51% | +4.37% | -24.25% | -10.18% | -36.72% | +196.78% | +105.47% | - | 11.92B | |
| +1.04% | +6.92% | -3.98% | +1.04% | -11.51% | +49.06% | +200.12% | +504.58% | +6,826.61% | 11.91B | |
| +6.52% | +13.99% | -2.49% | -17.75% | -14.98% | -48.12% | +735.39% | +83.58% | +122.94% | 11.86B | |
| +0.95% | +1.36% | -8.70% | +0.75% | +21.95% | +127.18% | +138.50% | +142.69% | +539.88% | 10.77B | |
| -1.24% | +7.89% | +0.77% | -13.25% | +17.71% | +30.99% | +122.44% | -29.14% | - | 9.29B | |
| +0.40% | +10.96% | +7.77% | +40.36% | +221.52% | +594.79% | +702.82% | -33.96% | -8.40% | 9.29B | |
| +0.08% | +0.47% | +0.68% | +124.52% | +80.77% | +213.41% | +401.19% | +378.12% | - | 8.93B | |
| +0.38% | +8.89% | +0.14% | +9.96% | +26.33% | +94.95% | +22.82% | +129.76% | - | 8.67B | |
| -1.96% | +4.76% | -8.88% | -11.99% | +278.28% | +206.97% | +331.70% | -34.47% | - | 7.94B | |
| Average | +0.94% | +6.66% | +4.33% | +22.23% | +53.54% | +114.91% | +256.10% | +201.91% | +1,678.05% | 19.51B | |
| Weighted average by Cap. | +1.51% | +9.32% | +9.38% | +27.15% | +44.09% | +84.45% | +203.56% | +184.79% | +2,452.19% |
- Stock Market
- Stocks
- BIOSGN Stock
- 8N10 Stock
- Sector Biosergen AB
Select your edition
All financial news and data tailored to specific country editions
